---
figid: PMC4807161__ijbsv12p0409g003
figlink: /pmc/articles/PMC4807161/figure/F3/
number: F3
caption: 'Physiological and anatomical targets of FDA-approved drugs for prostate
  cancer. LHRH produced by the hypothalamus stimulates production of LH by the anterior
  pituitary. LH then activates the production of testosterone by the testes. Gonadal
  testosterone, along with testosterone produced by the adrenal glands and the prostate
  itself, activates transcription of ARGs. Currently approved therapies for advanced
  PCa target multiple nodes along this physiological pathway. LHRH: Luteinizing hormone
  releasing hormone; LH: Luteinizing hormone; CYP17: Cytochrome P450-C17; T: Testosterone;
  DHT: Dihydrotestosterone; DHEA: Dehydroepiandrosterone; AR: androgen receptor; ARE:
  Androgen response element.'
pmcid: PMC4807161
papertitle: Therapeutic Rationales, Progresses, Failures, and Future Directions for
  Advanced Prostate Cancer.
reftext: Kristine M Wadosky, et al. Int J Biol Sci. 2016;12(4):409-426.
pmc_ranked_result_index: '26416'
pathway_score: 0.842408
filename: ijbsv12p0409g003.jpg
figtitle: Physiological and anatomical targets of FDA-approved drugs for prostate
  cancer
year: '2016'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4807161__ijbsv12p0409g003.html
  '@type': Dataset
  description: 'Physiological and anatomical targets of FDA-approved drugs for prostate
    cancer. LHRH produced by the hypothalamus stimulates production of LH by the anterior
    pituitary. LH then activates the production of testosterone by the testes. Gonadal
    testosterone, along with testosterone produced by the adrenal glands and the prostate
    itself, activates transcription of ARGs. Currently approved therapies for advanced
    PCa target multiple nodes along this physiological pathway. LHRH: Luteinizing
    hormone releasing hormone; LH: Luteinizing hormone; CYP17: Cytochrome P450-C17;
    T: Testosterone; DHT: Dihydrotestosterone; DHEA: Dehydroepiandrosterone; AR: androgen
    receptor; ARE: Androgen response element.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AR
  - GNRH1
  - CGA
  - CYP17A1
  - LHB
  - Nilutamide
  - Bicalutamide
  - Abiraterone
  - Enzalutamide
  - Cholesterol
  - DHEA
  - Flutamide
  - Ketoconazole
  - Leuprolide
  - Triptorelin
  - Finasteride
genes:
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: LHRH
  symbol: LHRH
  source: hgnc_prev_symbol
  hgnc_symbol: GNRH1
  entrez: '2796'
- word: LH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: CGA
  entrez: '1081'
- word: CYP17
  symbol: CYP17
  source: hgnc_prev_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: LH
  symbol: LH
  source: bioentities_symbol
  hgnc_symbol: LHB
  entrez: '3972'
chemicals:
- word: Nilutamide
  source: MESH
  identifier: C021277
- word: Bicalutamide
  source: MESH
  identifier: C053541
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: Enzalutamide
  source: MESH
  identifier: C540278
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: DHEA
  source: MESH
  identifier: D003687
- word: Flutamide
  source: MESH
  identifier: D005485
- word: Ketoconazole
  source: MESH
  identifier: D007654
- word: Leuprolide
  source: MESH
  identifier: D016729
- word: Triptorelin
  source: MESH
  identifier: D017329
- word: Finasteride
  source: MESH
  identifier: D018120
diseases: []
figid_alias: PMC4807161__F3
redirect_from: /figures/PMC4807161__F3
figtype: Figure
---
